Gemcitabine and vascular toxicity [2]

Lung Cancer

Volumn 37, Issue 2, 2002, Pages 229-

  Munoz A ^a   Manne J M ^a   Rubio, I ^a   Fernandez R ^a   Fuente, N ^a   Barcelo R ^a   Vivanco, G López ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; GEMCITABINE; TIOGUANINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ARTERY THROMBOSIS; CAPILLARY; CAPILLARY LEAK SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; DYSPNEA; EDEMA; ENDOTHELIUM INJURY; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; INTERSTITIAL LUNG DISEASE; KIDNEY FAILURE; LEG EDEMA; LETTER; LIVER VEIN OBSTRUCTION; LUNG CANCER; LUNG INFILTRATE; MUSCLE BIOPSY; PLEURA EFFUSION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEROLOGY; THROMBOCYTOPENIA; VASCULITIS; CHEMICALLY INDUCED DISORDER; LUNG TUMOR; NOTE; PATHOLOGY; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMAN; LUNG NEOPLASMS; TREATMENT OUTCOME; VASCULITIS; HUMANS;

EID: 0036321032     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00152-6     Document Type: Letter

References (8)

1. Vasculitis due to gemcitabine
2. Gemcitabine. A safety review
3. Fatal pulmonary toxicity resulting from treatment with gemcitabine
4. Fatal pulmonary toxicity resulting from treatment with gemcitabine
5. Veno-occlusive disease of the liver induced by gemcitabine
6. Hemolytic-uremic syndrome caused by gemcitabine
7. Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine. Description of four cases
8. Gemcitabine exerts a selective effect on the humoral immune response: Implications for combination chemoimmunotherapy